<DOC>
	<DOC>NCT01238393</DOC>
	<brief_summary>The purpose of this study is to determine whether intraocular injection of ranibizumab decreases the retinal thickness in patients with epiretinal membranes and reduces associated symptoms.</brief_summary>
	<brief_title>Treatment of Epiretinal Membranes With Ranibizumab</brief_title>
	<detailed_description />
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>symptomatic idiopathic epiretinal membrane vision worse than 6/18 and fit for surgery prior vitreoretinal surgery or injection diabetes any past or current form of retinal vein occlusion or neovascularization agerelated macular degeneration other condition causing significant limitation of visual potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>